Skip to main content
. 2016 Feb 2;14:26. doi: 10.1186/s12957-016-0778-8

Fig. 2.

Fig. 2

Scanning with 123-metaiodobenzylguanidine (I-123-MIBG) showing uptake on the proximal left femoral bone, suggestive of metastatic disease (a). Lower limb MRI revealing a proximal femoral lesion (b)

HHS Vulnerability Disclosure